Table 2.

HLA-specific alloreactivity potential.

Patient	AUC (nM.Peptide)
2	0.0361*106
4	0.1191*106
16	0.0417*106
23	0.1906*106
3	2.5802*106
5	0.4751*106
7	2.2249*106
8	1.9886*106
10	0.3754*106

All the peptides with an SMM-IC50 of <100 nM were plotted in order of ascending IC50, and the area under the curve for the resulting graph for each patient was determined (Formula 1). This value represents a summary measure of the number of peptides with a high binding affinity and their binding affinities in each DRP and is described by the dimensionless unit, nM.Peptide. See Figure 4 for the individual plots. Unrelated DRP are shaded gray.